What is a stock summary page? Click here for an overview.
Business Description
Vigil Neuroscience Inc
NAICS : 325412
SIC : 2834
ISIN : US92673K1088
Compare
Compare
Traded in other countries / regions
VIGL.USA Index Membership
Russell 2000Russell 2000Russell 3000 IPO Date
2022-01-07Description
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 7.56 | |||||
| Equity-to-Asset | 0.61 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -0.15 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -13.5 | |||||
| 3-Year EPS without NRI Growth Rate | -10.6 | |||||
| 3-Year FCF Growth Rate | 3.4 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 6.18 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 35.37 | |||||
| 9-Day RSI | 32.65 | |||||
| 14-Day RSI | 33.48 | |||||
| 3-1 Month Momentum % | 35.87 | |||||
| 6-1 Month Momentum % | -26.69 | |||||
| 12-1 Month Momentum % | -24.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.95 | |||||
| Quick Ratio | 2.95 | |||||
| Cash Ratio | 2.86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.1 | |||||
| Shareholder Yield % | -11.93 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -90.5 | |||||
| ROA % | -67.58 | |||||
| ROIC % | -328.25 | |||||
| 3-Year ROIIC % | -147.66 | |||||
| ROC (Joel Greenblatt) % | -526.96 | |||||
| ROCE % | -84.98 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.85 | |||||
| Price-to-Tangible-Book | 0.86 | |||||
| EV-to-EBIT | 0.22 | |||||
| EV-to-EBITDA | 0.22 | |||||
| EV-to-FCF | 0.24 | |||||
| Price-to-Net-Current-Asset-Value | 1.14 | |||||
| Price-to-Net-Cash | 1.19 | |||||
| Earnings Yield (Greenblatt) % | 454.55 | |||||
| FCF Yield % | -73.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VIGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Vigil Neuroscience Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.06 | ||
| Beta | 2.33 | ||
| 3-Year Sharpe Ratio | 0.11 | ||
| 3-Year Sortino Ratio | 0.21 | ||
| Volatility % | 84.31 | ||
| 14-Day RSI | 33.48 | ||
| 14-Day ATR ($) | 0.187856 | ||
| 20-Day SMA ($) | 1.795 | ||
| 12-1 Month Momentum % | -24.47 | ||
| 52-Week Range ($) | 1.312 - 6.06 | ||
| Shares Outstanding (Mil) | 46.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vigil Neuroscience Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vigil Neuroscience Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vigil Neuroscience Inc Frequently Asked Questions
What is Vigil Neuroscience Inc(VIGL)'s stock price today?
The current price of VIGL is $1.51. The 52 week high of VIGL is $6.06 and 52 week low is $1.31.
When is next earnings date of Vigil Neuroscience Inc(VIGL)?
The next earnings date of Vigil Neuroscience Inc(VIGL) is 2025-05-07 Est..
Does Vigil Neuroscience Inc(VIGL) pay dividends? If so, how much?
Vigil Neuroscience Inc(VIGL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers